ProCE Banner Activity

Advances in CAR T-Cell Therapy for Patients With Hematologic Malignancies

Slideset

Healthcare professionals caring for patients with hematologic malignancies review current and emerging CAR T-cell therapies and strategies for managing treatment-related toxicities and fostering equitable access to improve patient outcomes.

Released: March 21, 2025

Expiration: September 20, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Clinical Care Options, LLC (CCO) and Practicing Clinicians Exchange (PCE)

ProCE Banner

Supporters

Supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner